| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF816 ZNF727 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF221 DMRT3 ZNF157 KLF7 ZNF789 ZNF700 ZNF623 CTCF ZFP30 MEIS1 ZNF287 ZNF461 ZNF667 | 5.54e-13 | 1459 | 40 | 20 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF816 ZNF727 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF221 DMRT3 ZNF157 KLF7 ZNF789 ZNF700 ZNF623 CTCF ZFP30 MEIS1 ZNF287 ZNF461 | 3.84e-12 | 1412 | 40 | 19 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF816 ZNF727 ZNF311 IKZF1 ZNF845 ZNF701 ZNF221 DMRT3 ZNF157 KLF7 ZNF789 ZNF623 CTCF ZFP30 MEIS1 ZNF287 ZNF461 ZNF667 | 5.40e-12 | 1244 | 40 | 18 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF816 ZNF727 ZNF311 IKZF1 ZNF845 ZNF701 ZNF221 DMRT3 ZNF157 KLF7 ZNF789 ZNF623 CTCF ZFP30 MEIS1 ZNF287 ZNF461 ZNF667 | 7.74e-12 | 1271 | 40 | 18 | GO:0000987 |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.74e-04 | 10 | 40 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 7.27e-04 | 20 | 40 | 2 | GO:0042800 | |
| MousePheno | abnormal interventricular septum morphology | 2.45e-05 | 342 | 25 | 6 | MP:0000281 | |
| MousePheno | abnormal common myeloid progenitor cell morphology | 3.37e-05 | 105 | 25 | 4 | MP:0006410 | |
| MousePheno | abnormal heart septum morphology | 4.98e-05 | 388 | 25 | 6 | MP:0006113 | |
| MousePheno | thick myocardium | 6.41e-05 | 7 | 25 | 2 | MP:0010656 | |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 8.86e-05 | 263 | 25 | 5 | MP:0011099 | |
| MousePheno | lethality throughout fetal growth and development | 9.39e-05 | 435 | 25 | 6 | MP:0006208 | |
| MousePheno | abnormal myocardial trabeculae morphology | 1.15e-04 | 144 | 25 | 4 | MP:0002189 | |
| MousePheno | common ventricle | 2.37e-04 | 13 | 25 | 2 | MP:0010432 | |
| MousePheno | abnormal heart ventricle morphology | 3.60e-04 | 793 | 25 | 7 | MP:0005294 | |
| MousePheno | abnormal granulocyte number | 3.94e-04 | 805 | 25 | 7 | MP:0020201 | |
| Domain | zf-C2H2 | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF221 ZNF157 KLF7 ZNF789 ZNF700 ZNF623 CTCF ZFP30 ZNF287 ZNF461 ZNF667 | 5.89e-17 | 693 | 41 | 19 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF221 ZNF157 KLF7 ZNF789 ZNF700 ZNF623 CTCF ZFP30 ZNF287 ZNF461 ZNF667 | 6.05e-17 | 694 | 41 | 19 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF221 ZNF157 KLF7 ZNF789 ZNF700 ZNF623 CTCF ZFP30 ZNF287 ZNF461 ZNF667 | 4.60e-16 | 775 | 41 | 19 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF221 ZNF157 KLF7 ZNF789 ZNF700 ZNF623 CTCF ZFP30 ZNF287 ZNF461 ZNF667 | 4.83e-16 | 777 | 41 | 19 | PS00028 |
| Domain | KRAB | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 ZNF845 ZNF701 ZNF221 ZNF157 ZNF789 ZNF700 ZFP30 ZNF287 ZNF461 ZNF667 | 5.22e-16 | 358 | 41 | 15 | PS50805 |
| Domain | KRAB | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 ZNF845 ZNF701 ZNF221 ZNF157 ZNF789 ZNF700 ZFP30 ZNF287 ZNF461 ZNF667 | 5.22e-16 | 358 | 41 | 15 | PF01352 |
| Domain | Znf_C2H2-like | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF221 ZNF157 KLF7 ZNF789 ZNF700 ZNF623 CTCF ZFP30 ZNF287 ZNF461 ZNF667 | 7.51e-16 | 796 | 41 | 19 | IPR015880 |
| Domain | KRAB | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 ZNF845 ZNF701 ZNF221 ZNF157 ZNF789 ZNF700 ZFP30 ZNF287 ZNF461 ZNF667 | 8.18e-16 | 369 | 41 | 15 | SM00349 |
| Domain | KRAB | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 ZNF845 ZNF701 ZNF221 ZNF157 ZNF789 ZNF700 ZFP30 ZNF287 ZNF461 ZNF667 | 8.51e-16 | 370 | 41 | 15 | IPR001909 |
| Domain | - | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF221 ZNF157 KLF7 ZNF789 ZNF700 ZNF623 CTCF ZFP30 ZNF461 ZNF667 | 9.12e-16 | 679 | 41 | 18 | 3.30.160.60 |
| Domain | Znf_C2H2 | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF221 ZNF157 KLF7 ZNF789 ZNF700 ZNF623 CTCF ZFP30 ZNF287 ZNF461 ZNF667 | 9.22e-16 | 805 | 41 | 19 | IPR007087 |
| Domain | ZnF_C2H2 | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF221 ZNF157 KLF7 ZNF789 ZNF700 ZNF623 CTCF ZFP30 ZNF287 ZNF461 ZNF667 | 9.87e-16 | 808 | 41 | 19 | SM00355 |
| Domain | zf-C2H2_6 | ZNF816 ZNF727 ZNF311 ZNF20 ZNF845 ZNF701 ZNF157 ZNF789 ZNF700 ZFP30 ZNF461 ZNF667 | 2.11e-12 | 314 | 41 | 12 | PF13912 |
| Domain | zf-MYND | 1.27e-05 | 21 | 41 | 3 | PF01753 | |
| Domain | Znf_MYND | 1.47e-05 | 22 | 41 | 3 | IPR002893 | |
| Domain | ZF_MYND_1 | 1.47e-05 | 22 | 41 | 3 | PS01360 | |
| Domain | ZF_MYND_2 | 1.47e-05 | 22 | 41 | 3 | PS50865 | |
| Domain | GPS | 2.52e-03 | 34 | 41 | 2 | SM00303 | |
| Domain | GPS | 2.67e-03 | 35 | 41 | 2 | PF01825 | |
| Domain | GPS | 2.83e-03 | 36 | 41 | 2 | PS50221 | |
| Domain | GPS | 2.98e-03 | 37 | 41 | 2 | IPR000203 | |
| Domain | SET | 3.65e-03 | 41 | 41 | 2 | PF00856 | |
| Domain | SET | 4.58e-03 | 46 | 41 | 2 | SM00317 | |
| Domain | SET_dom | 5.39e-03 | 50 | 41 | 2 | IPR001214 | |
| Domain | SET | 5.39e-03 | 50 | 41 | 2 | PS50280 | |
| Domain | C1_1 | 6.95e-03 | 57 | 41 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 8.70e-03 | 64 | 41 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 8.70e-03 | 64 | 41 | 2 | PS50081 | |
| Domain | C1 | 8.96e-03 | 65 | 41 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 9.23e-03 | 66 | 41 | 2 | IPR002219 | |
| Domain | LIM | 1.01e-02 | 69 | 41 | 2 | PF00412 | |
| Domain | - | 1.03e-02 | 70 | 41 | 2 | 2.10.110.10 | |
| Domain | LIM_DOMAIN_2 | 1.06e-02 | 71 | 41 | 2 | PS50023 | |
| Domain | Znf_LIM | 1.06e-02 | 71 | 41 | 2 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.06e-02 | 71 | 41 | 2 | PS00478 | |
| Domain | LIM | 1.06e-02 | 71 | 41 | 2 | SM00132 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZIM2 ZNF727 ZNF311 ZNF20 ZNF701 ZNF221 ZNF157 ZNF700 LMO2 ZFP30 SMYD2 ZNF287 ZNF461 ZNF667 | 3.95e-07 | 1387 | 31 | 14 | M734 |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 1.92e-04 | 768 | 31 | 8 | MM14851 | |
| Pubmed | 1.24e-07 | 199 | 41 | 6 | 23382691 | ||
| Pubmed | Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease. | 1.36e-06 | 2 | 41 | 2 | 28604386 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 31757932 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 29273751 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 28084409 | ||
| Pubmed | Requirement of protein kinase D1 for pathological cardiac remodeling. | 1.36e-06 | 2 | 41 | 2 | 18287012 | |
| Pubmed | PKD1/PKCmu promotes alphavbeta3 integrin recycling and delivery to nascent focal adhesions. | 1.36e-06 | 2 | 41 | 2 | 15192707 | |
| Pubmed | 2.33e-06 | 181 | 41 | 5 | 37372979 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 20877461 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 27179075 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 23129748 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 15738054 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 15623513 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 16805913 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 19011111 | ||
| Pubmed | Upstream distal regulatory elements contact the Lmo2 promoter in mouse erythroid cells. | 3.78e-05 | 8 | 41 | 2 | 23285212 | |
| Pubmed | Cardiac deletion of Smyd2 is dispensable for mouse heart development. | 1.05e-04 | 13 | 41 | 2 | 20305823 | |
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 28065741 | ||
| Pubmed | 1.41e-04 | 15 | 41 | 2 | 31552487 | ||
| Pubmed | Role of the ANKMY2-FKBP38 axis in regulation of the Sonic hedgehog (Shh) signaling pathway. | 1.61e-04 | 16 | 41 | 2 | 25077969 | |
| Pubmed | 2.05e-04 | 18 | 41 | 2 | 20887958 | ||
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 26511239 | ||
| Pubmed | 3.68e-04 | 24 | 41 | 2 | 22632720 | ||
| Pubmed | 4.33e-04 | 26 | 41 | 2 | 26857994 | ||
| Pubmed | PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. | 4.90e-04 | 130 | 41 | 3 | 26598620 | |
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 5.03e-04 | 28 | 41 | 2 | 27002738 | |
| Pubmed | 5.39e-04 | 29 | 41 | 2 | 24105743 | ||
| Interaction | ZNF710 interactions | 2.83e-05 | 30 | 40 | 3 | int:ZNF710 | |
| Interaction | GLIS1 interactions | 2.83e-05 | 30 | 40 | 3 | int:GLIS1 | |
| Interaction | ZFP3 interactions | 2.83e-05 | 30 | 40 | 3 | int:ZFP3 | |
| Interaction | ZNF382 interactions | 3.79e-05 | 33 | 40 | 3 | int:ZNF382 | |
| Interaction | ZNF697 interactions | 3.79e-05 | 33 | 40 | 3 | int:ZNF697 | |
| Interaction | ZNF513 interactions | 4.15e-05 | 34 | 40 | 3 | int:ZNF513 | |
| Interaction | SALL3 interactions | 4.15e-05 | 34 | 40 | 3 | int:SALL3 | |
| Interaction | ZNF652 interactions | 4.54e-05 | 35 | 40 | 3 | int:ZNF652 | |
| Interaction | CENPB interactions | 1.05e-04 | 124 | 40 | 4 | int:CENPB | |
| Interaction | ZSCAN21 interactions | 1.19e-04 | 128 | 40 | 4 | int:ZSCAN21 | |
| Interaction | ZFP37 interactions | 1.25e-04 | 49 | 40 | 3 | int:ZFP37 | |
| Interaction | PRDM4 interactions | 1.50e-04 | 52 | 40 | 3 | int:PRDM4 | |
| Interaction | ZNF667 interactions | 1.58e-04 | 53 | 40 | 3 | int:ZNF667 | |
| Interaction | ZNF473 interactions | 1.87e-04 | 56 | 40 | 3 | int:ZNF473 | |
| Interaction | ZNF287 interactions | 2.29e-04 | 60 | 40 | 3 | int:ZNF287 | |
| Interaction | HOXD11 interactions | 2.50e-04 | 12 | 40 | 2 | int:HOXD11 | |
| Interaction | CTCFL interactions | 2.53e-04 | 62 | 40 | 3 | int:CTCFL | |
| Interaction | KRTAP10-7 interactions | 2.72e-04 | 293 | 40 | 5 | int:KRTAP10-7 | |
| Interaction | ZNF787 interactions | 2.78e-04 | 64 | 40 | 3 | int:ZNF787 | |
| Interaction | ZNF423 interactions | 4.09e-04 | 73 | 40 | 3 | int:ZNF423 | |
| Interaction | TRIM28 interactions | ZIM2 ZNF816 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF789 ZFP30 ZNF287 | 4.73e-04 | 1474 | 40 | 10 | int:TRIM28 |
| Interaction | PRDM5 interactions | 5.35e-04 | 80 | 40 | 3 | int:PRDM5 | |
| Interaction | RBAK interactions | 5.55e-04 | 81 | 40 | 3 | int:RBAK | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | IZUMO1 ZIM2 IGFL1 ZNF816 ZNF845 ZNF701 ZNF221 ZFP30 ZNF461 ZNF667 | 7.23e-08 | 1192 | 41 | 10 | chr19q13 |
| Cytoband | 19q13.12 | 1.91e-03 | 72 | 41 | 2 | 19q13.12 | |
| Cytoband | 19q13.41 | 2.24e-03 | 78 | 41 | 2 | 19q13.41 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZIM2 ZNF816 ZNF727 ZNF311 ZNF20 IKZF1 ZNF845 ZNF701 ZNF221 ZNF157 KLF7 ZNF789 ZNF700 ZNF623 CTCF ZFP30 ZNF287 ZNF461 ZNF667 | 4.24e-18 | 718 | 35 | 19 | 28 |
| GeneFamily | Zinc fingers MYND-type | 8.63e-06 | 21 | 35 | 3 | 87 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.96e-03 | 34 | 35 | 2 | 487 | |
| GeneFamily | LIM domain containing | 5.81e-03 | 59 | 35 | 2 | 1218 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP | 5.66e-06 | 290 | 41 | 6 | M11616 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.79e-07 | 176 | 41 | 5 | 4ed73c73972334f6dc4229920205547823252fa0 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-05 | 148 | 41 | 4 | cb9365663f9cba35d47b5dd9079f42e88b70d915 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.59e-05 | 187 | 41 | 4 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 2.65e-05 | 188 | 41 | 4 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.71e-05 | 189 | 41 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | P07-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.76e-05 | 190 | 41 | 4 | 5d25e40bc2cca314f4265e4001a546e6d99e2a79 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.12e-05 | 196 | 41 | 4 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | distal-3-Endothelial-Capillary_Aerocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.37e-05 | 200 | 41 | 4 | e12598a097dd9c4cbf9bb85bfa3057722ef73ad5 | |
| ToppCell | severe-NK_CD56bright|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.37e-05 | 200 | 41 | 4 | 82818ab1796fdd0b8be02b341818897595eed841 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.12e-04 | 126 | 41 | 3 | e33957cf1541733b06de9f9e7b2801b3d8ae831d | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.37e-04 | 131 | 41 | 3 | cc5b5afab8622e98f673fa116a226d930c295327 | |
| ToppCell | Control-NK|World / Disease group and Cell class | 3.07e-04 | 143 | 41 | 3 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.19e-04 | 145 | 41 | 3 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-04 | 150 | 41 | 3 | 7290e9a812b1b2f919e67ccde0acf52687ab138f | |
| ToppCell | LPS_only-Hematopoietic_Mast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-04 | 150 | 41 | 3 | 2c5078a1f769ba8153dee756b53d28eb7b434a96 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.11e-04 | 158 | 41 | 3 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.50e-04 | 163 | 41 | 3 | c21114826bee1b05b411984326fef6b6e0d05316 | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.50e-04 | 163 | 41 | 3 | 03b2ec226adffba3ce893f3d12e549c841e662fd | |
| ToppCell | E12.5-Endothelial-lymphatic_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.50e-04 | 163 | 41 | 3 | 5d49414432db259a19df50d7944581d00b69f537 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.58e-04 | 164 | 41 | 3 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-04 | 165 | 41 | 3 | 50a8513d8d2630861499393a7f102b35366bad37 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.83e-04 | 167 | 41 | 3 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.83e-04 | 167 | 41 | 3 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 4.91e-04 | 168 | 41 | 3 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-04 | 169 | 41 | 3 | a54a8494c1feff29d77ab4737fcfabc84ace5c94 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.08e-04 | 170 | 41 | 3 | 4848965bc7e9356c6601bb41eeea1553d2eea87e | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 5.08e-04 | 170 | 41 | 3 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.35e-04 | 173 | 41 | 3 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.44e-04 | 174 | 41 | 3 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-04 | 177 | 41 | 3 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-04 | 177 | 41 | 3 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-04 | 178 | 41 | 3 | c90e9048fc786ba8559972ae25c25ecab4bc1b7c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.81e-04 | 178 | 41 | 3 | 9e426ce23a4a33b91d139ad85685cf8483bcd01a | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 6.00e-04 | 180 | 41 | 3 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 6.00e-04 | 180 | 41 | 3 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.00e-04 | 180 | 41 | 3 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 6.10e-04 | 181 | 41 | 3 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | (0)_Normal/No_Treatment|World / Stress and Cell class | 6.10e-04 | 181 | 41 | 3 | 4077282c45a37403f47e8d1b9ac102e6b1ba2cf9 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-04 | 182 | 41 | 3 | e7138c8d3821b4141c4b1b23dab6d9b4e99fd4b2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.20e-04 | 182 | 41 | 3 | 209b455eaa135825fa6e6c71bf7d2072cebf11f2 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 6.20e-04 | 182 | 41 | 3 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 6.20e-04 | 182 | 41 | 3 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 6.50e-04 | 185 | 41 | 3 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | P07-Endothelial-capillary_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.60e-04 | 186 | 41 | 3 | 72aab20b848dd9e1101a4bc2466e08aed5f8bbb6 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-04 | 186 | 41 | 3 | f14722ecc832794dc267bf3f9b8a13274c3addc1 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.71e-04 | 187 | 41 | 3 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.71e-04 | 187 | 41 | 3 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.71e-04 | 187 | 41 | 3 | 02e7246ef5ad41773d14426254e139b156d45c1d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.71e-04 | 187 | 41 | 3 | 97b2463fb37e7196dd2f92553acf8e7bc3ec40dd | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.71e-04 | 187 | 41 | 3 | 08c73d125e0638c9e9878165bba2442c266c8a48 | |
| ToppCell | E17.5-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.71e-04 | 187 | 41 | 3 | 1f358d02ec69d44dea2e2831af9473ed05dcf8cc | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.71e-04 | 187 | 41 | 3 | e9aa0a5a0f8e2593de63e83b56b53ae33e60af49 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.71e-04 | 187 | 41 | 3 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | E17.5-Endothelial-unknown_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.71e-04 | 187 | 41 | 3 | da885c26ccc5189b1ff1f607552e00a5c0e49e7e | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.71e-04 | 187 | 41 | 3 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | E17.5-Endothelial-capillary_endothelial_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.71e-04 | 187 | 41 | 3 | 61b8a53f29bb8b33c69f680b8359a1143a23999d | |
| ToppCell | P03-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell_of_alveolus|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.71e-04 | 187 | 41 | 3 | 55618ceec367c1c51ed5c447063d7fbd5c7e0808 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 6.71e-04 | 187 | 41 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 6.81e-04 | 188 | 41 | 3 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 6.81e-04 | 188 | 41 | 3 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.81e-04 | 188 | 41 | 3 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | P03-Endothelial-capillary_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.81e-04 | 188 | 41 | 3 | ede354ca550840d8f0c8dac22d8ce1f1d325886a | |
| ToppCell | COVID-NK-|COVID / Condition, Cell_class and T cell subcluster | 6.81e-04 | 188 | 41 | 3 | fabdd68a9734d35e75e1f4a4bfd5c531cfc099f1 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 188 | 41 | 3 | e1f18c11e4848978ca7bbe9271917da14b3f0523 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 188 | 41 | 3 | 283a7a22db144e8f942904d4a38cac30874f6d9e | |
| ToppCell | facs-Marrow-KLS-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 188 | 41 | 3 | 31977e5f522c19992f0ac6d46e183533ab2607e9 | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 6.81e-04 | 188 | 41 | 3 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | P03-Endothelial|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.81e-04 | 188 | 41 | 3 | 88d477aad98be124919b9c6b0b8dbd24e556422e | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.81e-04 | 188 | 41 | 3 | cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_endothelial_cell_-_unspecif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.81e-04 | 188 | 41 | 3 | 764fe0498288defa2d959bc01c07da0b54ea9814 | |
| ToppCell | COVID-NK|COVID / Condition, Cell_class and T cell subcluster | 6.81e-04 | 188 | 41 | 3 | 0beaa671611110a11e46156f54f5202cc24967a4 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.81e-04 | 188 | 41 | 3 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.92e-04 | 189 | 41 | 3 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-04 | 189 | 41 | 3 | 533685a921a65d84107d8d33c43b4fffde019143 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-04 | 189 | 41 | 3 | dca56ab02bf0505f9a352ff907edaef30906d854 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 6.92e-04 | 189 | 41 | 3 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.92e-04 | 189 | 41 | 3 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | facs-Marrow-KLS|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-04 | 189 | 41 | 3 | 4214abfa07b047e256df43e472f9a835a18ed7a3 | |
| ToppCell | P07-Endothelial-unknown_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.92e-04 | 189 | 41 | 3 | f515a04ae1746257d4568cea13a3dd75b4b05275 | |
| ToppCell | P07-Endothelial|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.92e-04 | 189 | 41 | 3 | d62b5b5c3cd259befa7afb19f45e3804e2ab80f7 | |
| ToppCell | P07-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.92e-04 | 189 | 41 | 3 | fcfb28bd96471affc13e55aa7228f594aaa967cd | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.02e-04 | 190 | 41 | 3 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 7.02e-04 | 190 | 41 | 3 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-04 | 190 | 41 | 3 | 11f32f46661e44770782b8ec13c00028e1dfc3cd | |
| ToppCell | facs-Marrow-KLS-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-04 | 190 | 41 | 3 | a513c1e7df62c28128c932a68b252ee8f0255172 | |
| ToppCell | P03-Endothelial-unknown_endothelial_cell-endothelial_unknown_1|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.02e-04 | 190 | 41 | 3 | 347c7bf67ade235a4e2320db6a75ce0dab8744f9 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-04 | 190 | 41 | 3 | 3bd422755ce1d9854dbfebca7b28afa1d03d595c | |
| ToppCell | P03-Endothelial-unknown_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.02e-04 | 190 | 41 | 3 | 0c7da05fbd3f095dde7550585209c056f0b76990 | |
| ToppCell | E17.5-Endothelial|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.02e-04 | 190 | 41 | 3 | 4fb76195ec9d6e0260a628eef6c2b3705acce787 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.02e-04 | 190 | 41 | 3 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.02e-04 | 190 | 41 | 3 | 20f4f6fe09345878484086047061d6f900f9d476 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.13e-04 | 191 | 41 | 3 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.13e-04 | 191 | 41 | 3 | 718330bb97fe8a1ffd0c82e9af23311a32eacfe1 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.13e-04 | 191 | 41 | 3 | 454034ad940377ee079afa8ce33f8e0bdeaf44f8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.13e-04 | 191 | 41 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | facs-Marrow-KLS-18m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.13e-04 | 191 | 41 | 3 | 51327ba28b2e3052087fa0fc9b7c0339dc09a1e3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.24e-04 | 192 | 41 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.24e-04 | 192 | 41 | 3 | 959c28d28397bc0b9d3970d1fe3293d2750e63d4 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.24e-04 | 192 | 41 | 3 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.24e-04 | 192 | 41 | 3 | 2360824910cd471c8286ca369ba144d90d984602 | |
| Disease | serum IgG glycosylation measurement | 6.93e-05 | 523 | 40 | 6 | EFO_0005193 | |
| Disease | retinal detachment, retinal break | 1.04e-03 | 35 | 40 | 2 | EFO_0005773, EFO_0010698 | |
| Disease | Malignant neoplasm of salivary gland | 1.71e-03 | 45 | 40 | 2 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 1.86e-03 | 47 | 40 | 2 | C0036095 | |
| Disease | phosphoglycerides measurement | 1.94e-03 | 48 | 40 | 2 | EFO_0022291 | |
| Disease | disease recurrence, colon carcinoma | 2.19e-03 | 51 | 40 | 2 | EFO_0004952, EFO_1001950 | |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.36e-03 | 53 | 40 | 2 | C1961099 | |
| Disease | diet measurement | 2.72e-03 | 1049 | 40 | 6 | EFO_0008111 | |
| Disease | triglycerides in IDL measurement | 2.82e-03 | 58 | 40 | 2 | EFO_0022149 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 3.64e-03 | 228 | 40 | 3 | EFO_0003948, MONDO_0004975 | |
| Disease | triglycerides in very small VLDL measurement | 3.86e-03 | 68 | 40 | 2 | EFO_0022144 | |
| Disease | renal cell carcinoma (is_implicated_in) | 3.97e-03 | 69 | 40 | 2 | DOID:4450 (is_implicated_in) | |
| Disease | allergic disease, age at onset | 4.20e-03 | 71 | 40 | 2 | EFO_0004847, MONDO_0005271 | |
| Disease | stem Cell Growth Factor beta measurement | 4.67e-03 | 75 | 40 | 2 | EFO_0008292 | |
| Disease | carotid plaque build | 5.82e-03 | 84 | 40 | 2 | EFO_0006501 | |
| Disease | response to anticonvulsant | 5.96e-03 | 85 | 40 | 2 | GO_0036277 | |
| Disease | red blood cell density measurement | 6.47e-03 | 880 | 40 | 5 | EFO_0007978 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NEKRFKCDQCDYACR | 491 | P49711 | |
| VRKEYGKCFRHSYCC | 1091 | O95490 | |
| KCAACQKHFCVGDRY | 121 | P25791 | |
| SADCKFTCHYRCRAL | 86 | Q9NS23 | |
| CDNFCHRYISCLKGK | 166 | O00470 | |
| THDCCYKRLEKRGCG | 66 | P14555 | |
| KCEGCGLNYHKRCAF | 176 | Q15139 | |
| GKFFHRSCFKCEYCA | 781 | Q7RTP6 | |
| YAERGACKKCHSSCR | 851 | Q86XX4 | |
| KNCRCDGKIVYCESH | 36 | Q86VH4 | |
| KKGYDLAFRFCSCRC | 166 | Q9UBI9 | |
| AKPFKCNHCDRCFSR | 276 | O75840 | |
| KPFKCHLCNYACRRR | 171 | Q13422 | |
| LKGHKRYCRFKDCTC | 41 | Q9NQL9 | |
| KRCGDKFYDPLQHCC | 41 | Q6UW32 | |
| CRSSFYCCKEHQRQD | 36 | Q9GZT9 | |
| NCKKEVHACRKSYDC | 151 | Q8IYV9 | |
| CYCESCRKLRGDEAH | 1366 | Q96JN8 | |
| RCRQGHCEEFCVYKG | 2516 | P98161 | |
| AYGKRHCDQACCMEK | 1141 | B5MCY1 | |
| KLHRCGQCKFAHYCD | 61 | Q8NB12 | |
| GQCKFAHYCDRTCQK | 66 | Q8NB12 | |
| CGTCYYRFCCKKRHE | 121 | Q6ZSJ9 | |
| HNEERSYKCNRCGKF | 601 | Q96IR2 | |
| YRCNKCEKVCNRHSS | 386 | Q5HYK9 | |
| YKCEECHKAFRCCSD | 256 | A8MUV8 | |
| CGKAFRCCNSLRYHE | 541 | Q9H0M5 | |
| YECKQCGKAFRCGSH | 311 | P17024 | |
| NFECHECGKAYCRKS | 161 | P51786 | |
| YECKECGKAFRQCAH | 186 | Q9Y2G7 | |
| ECKECGKAFRQYAHL | 271 | Q9Y2G7 | |
| RIHSGEKCYKCNECG | 556 | Q9HBT7 | |
| RKHDYVGERACQCCD | 456 | Q9NZV7 | |
| YKCEQCGKGFICRRD | 366 | Q9UK13 | |
| CDVCGKDFHQKRYLA | 311 | Q9NV72 | |
| YECKECGKAFRHRSD | 291 | O75123 | |
| HCEYCFTRKEGLSKC | 51 | Q9NRG4 | |
| CGRCKDKRFSCGNIY | 301 | A6NP61 | |
| HRCHTGEKTYKCNEC | 276 | Q0VGE8 | |
| YECKECGKTFRQCSH | 441 | Q8TAF7 | |
| SEKHYEHLGRCCNKC | 36 | Q9Y6Q6 | |
| PYRCHDCGKCFRQLA | 256 | Q5FWF6 | |
| YRCEECGKAFRHNCK | 471 | Q5JNZ3 |